LONDON and SALT LAKE CITY, Feb. 15, 2024 (GLOBE NEWSWIRE) Renalytix plc (NASDAQ: RNLX) (LSE: RENX) (the “Company”), an artificial intelligence-enabled.
Electronic health record deployment of KidneyIntelX was associated with clinical actions that slowed progression of chronic kidney disease and improved.
Renalytix Plc (NASDAQ:RNLX – Get Free Report)’s share price traded up 2.2% during mid-day trading on Wednesday . The company traded as high as $0.39 and last traded at $0.37. 52,849 shares traded hands during trading, a decline of 77% from the average session volume of 227,914 shares. The stock had previously closed at $0.37. […]
Renalytix Plc (NASDAQ:RNLX – Get Free Report) was the recipient of a large increase in short interest during the month of October. As of October 15th, there was short interest totalling 210,000 shares, an increase of 32.4% from the September 30th total of 158,600 shares. Based on an average trading volume of 76,400 shares, the […]